Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse.

Mnemonic
U AMP
Methodology

Enzyme Immunoassay

Performed

Sun-Sat

Reported

Within 24 hours

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Random urine.

Specimen Preparation

Mix well. Transfer 4 mL urine to an ARUP Standard Transport Tube. (Min: 1 mL)

Storage/Transport Temperature

Refrigerated. Also acceptable: Room temperature or frozen.

Unacceptable Conditions

Specimens exposed to repeated freeze/thaw cycles.

Remarks
Stability

Ambient: 1 week; Refrigerated: 5 days; Frozen: 3 years

Reference Interval

Negative

Interpretive Data

This test detects d-amphetamine, d-methamphetamine, methylenedioxyamphetamine (MDA), and methylenedioxymethamphetamine (MDMA) in human urine. It does not detect l-ephedrine, d-ephedrine, d-pseudoephedrine, l-pseudoephedrine, and phenylpropanolamine. Results greater than or equal to the 1000 ng/mL cutoff are positive. This is a screening test, results are unconfirmed and should be used for medical (treatment) purposes only.

Compliance Category

FDA

Note
Hotline History
N/A
CPT Codes

80307

Components
Component Test Code* Component Chart Name LOINC
0090302 Stimulant Amines Detection 3349-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Amphetamine, qualitative urine
  • methamphetamine screen
  • Stimulant Amines tox screen
  • Stimulantss urine tox screen
  • Substance abuse screening
Drugs of Abuse Screen - Stimulant Amines - Urine